According to the World Health Organization, cardiovascular diseases (CVDs) are the leading cause of death worldwide, killing an estimated 17.9 million people each year. Cardiovascular diseases are a group of diseases of the heart and blood vessels, which include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other pathologies. More than four out of five deaths from CVDs occur because of heart attack and stroke, and a third of these deaths are premature and occur in people under 70 years of age. [1]

Cardiovascular diseases (who.int).

Bockeria L.A., Revishvili A.Sh., Neminushchiy N.M. Treatment of heart failure using cardiac resynchronization. Pacific Medical Journal. 2008; 1:5–11. [Bokeriya LA, Revishvili AS, Neminushchiy NM. The treatment of the cardiac insufficiency by the method of the cardiac resynchronization. Pacific Medical Journal. 2008; 1:5–11 (In Russ).]

International Diabetes Federation. IDF Diabetes Atlas. Eighth ed. Brussels: IDF; 2017.

Domanski M, Krause-Steinrauf H, Deedwania P, Follmann D, Ghali JK, Gilbert E, et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol. 2003; 42(5):914–22.

Wang Y, Negishi T, Negishi K, Marwick TH. Prediction of heart failure in patients with type 2 diabetes mellitus – a systematic review and meta-analysis. Diabetes Res Clin Pract. 2015; 108(1):55–66.

Dedov I.I. Diabetes mellitus: development of technologies in diagnosis, treatment and prevention. Diabetes. 2010; 3:6–13. [Dedov II. Diabetes mellitus: Development of technologies in diagnosis, treatment and prevention. Diabetes Mellitus. 2010; 3:6–13 (In Russ).]

Vanhecke TE, Kim R, Raheem SZ, McCullough PA. Myocardial ischemia in patients with diastolic dysfunction and heart failure. Curr Cardiol Rep. 2010; 12:216–22.

Arbolishvili G.N., Mareev V.Yu., Orlova Y.A. Belenkov Yu.N. Relationship between various indicators of rhythm variability and the mechanism of death in patients with chronic heart failure and left ventricular systolic dysfunction. Heart failure. 2006; 7(4):172–8. [Arbolishvili GN, Mareev VYu, Orlova YaA. Belenkov YuN. The relationship of various indicators of rhythm variability with the mechanism of death in patients with chronic heart failure and left ventricular systolic dysfunction. Heart failure. 2006; 7(4):172–8 (In Russ).]

Meshcherina N.S., Guseinova N.S. STRUCTURAL AND FUNCTIONAL PARAMETERS OF THE HEART IN COMORBID PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES // Modern problems of science and education. – 2020. – No. 6.

Instructions for medical use of the drug Jardins. Registration certificate LP-002735 dated 2015.

https://wsjournal.ru/empagliflozin-novye-vozmozhnosti-dlya-terapii-patsientov-s-serdechnoj-nedostatochnostyu/?ysclid=lgaqvtmwi612840938

Smith WM. Epidemiology of congestive heart failure. Am J